Trump of­fi­cials said in­dus­try did­n't want FDA's stricter vac­cine guid­ance, but the lead­ing de­vel­op­er says they nev­er dis­cussed it

There are four weeks to the elec­tion. Se­nior Trump of­fi­cials are now cit­ing in­dus­try op­po­si­tion as the rea­son they are block­ing the FDA from mak­ing of­fi­cial their pro­posed EUA+ vac­cine guide­lines, which, if en­forced, would dim the pos­si­bil­i­ty of a pre-Elec­tion Day ap­proval.

These rev­e­la­tions come from a pair of new re­ports out last night from the New York Times and Politi­co. But al­most as soon as they came out, in­dus­try in­sid­ers be­gan push­ing back on the al­le­ga­tions. For­mer FDA chief Scott Got­tlieb said he had nev­er heard in any­one in phar­ma ex­press that view, and Pfiz­er CEO Al­bert Bourla said he had nev­er dis­cussed the is­sue with the White House.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER